Skip to main content

Table 2 Details of 22 patients initially managed with observation

From: Outcome of lung metastases due to bone giant cell tumor initially managed with observation

Case

Interval between surgery of primary tumor and discovery of lung metastasis (months)

Number of lung nodules

Size of maximum nodule (mm)

Lung lesion

Laterality

Progression of lung lesions

Time to progression from discovery of lung metastasis (months)

Treatment for lung lesions

Interval between lung metastasis and metastasectomy (months)

Follow-up period from surgery for primary tumor (months)

Follow-up period from discovery of lung metastasis (months)

Status

1

44

NA

NA

Multiple

Bilateral

No

 

Observation

 

139

93

AWD

2

0

4

NA

Solitary

Unilateral

No

 

Observation

 

34

33

AWD

3

0

NA

NA

Multiple

Bilateral

Yes

10

Metastasectomy

14

42

42

AWD

4

43

NA

5

Multiple

Bilateral

No

 

Observation

 

173

117

AWD

5

16

7

NA

Multiple

Bilateral

Yes

4

Metastasectomy

4

92

75

NED

6

35

NA

10

Multiple

Bilateral

Yes

14

Observation

 

89

52

AWD

7

22

10

5

Multiple

Bilateral

No

 

Observation

 

42

20

AWD

8

0

4

5

Multiple

Bilateral

No

 

Observation

 

134

133

AWD

9

23

3

3

Multiple

Bilateral

Yes

11

Metastasectomy

9

52

29

AWD

10

24

5

5

Multiple

Bilateral

Yes

5

Metastasectomy

5

181

155

NED

11

11

6

5

Multiple

Bilateral

Yes

15

Metastasectomy

15

164

150

AWD

12

0

10

10

Multiple

Bilateral

Yes

5

Denosumab

 

118

116

AWD

13

64

3

NA

Multiple

Bilateral

No

 

Observation

 

114

48

AWD

14

11

3

30

Multiple

Unilateral

Yes

6

Metastasectomy

62

141

128

NED

15

30

7

3

Multiple

Bilateral

Yes

66

Metastasectomy

69

118

86

NED

16

23

1

5

Multiple

Bilateral

No

 

Observation

 

76

51

AWD

17

46

4

5

Multiple

Bilateral

Yes

3

Observation

 

120

72

AWD

18

44

NA

NA

Multiple

Bilateral

No

 

Observation

 

73

28

AWD

19

10

3

3

Multiple

Bilateral

No

 

Observation

 

150

138

AWD

20

40

1

5

Solitary

Unilateral

No

 

Observation

 

89

48

AWD

21

0

2

12

Multiple

Bilateral

Yes

5

Metastasectomy

6

183

181

NED

22

0

NA

6

Multiple

Bilateral

Yes

36

Denosumab

 

87

91

AWD

  1. NA not available, NED no evidence of disease, AWD alive with disease